Cargando…
log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males
BACKGROUND: T2DM is associated with atherogenic dyslipidemia (AD), defined as decreased HDL-C plus raised triglycerides (TG). AD confers increased risk for CAD, even when LDL-C is at target. AD is rarely assessed due to lack of screening methods consensus. AIM: To establish the prevalence and severi...
Autores principales: | Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020173/ https://www.ncbi.nlm.nih.gov/pubmed/21156040 http://dx.doi.org/10.1186/1475-2840-9-88 |
Ejemplares similares
-
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females
por: Hermans, Michel P, et al.
Publicado: (2012) -
Non-HDL-cholesterol as valid surrogate to apolipoprotein B(100 )measurement in diabetes: Discriminant Ratio and unbiased equivalence
por: Hermans, Michel P, et al.
Publicado: (2011) -
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B(100) in patients with T2DM
por: Hermans, Michel P, et al.
Publicado: (2013) -
Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids
por: Hermans, Michel P, et al.
Publicado: (2014) -
Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies
por: Hermans, Michel P., et al.
Publicado: (2015)